Back

An allogeneic bioengineered myocardial graft limits infarct size and improves cardiac function: pre-clinical study in the porcine myocardial infarction model

28 August 2016 (14:00 - 18:00)
Organised by:
Congress Presentation Part of: Poster session 3 - Stem cells and cell therapy Stem cells and cell therapy ESC Premium Access ESC Congress 2016

About the speaker

Photo
Doctor Carol Galvez-Monton

Health Science Research Institute Germans Trias i Pujol (IGTP), Badalona (Spain)

14 More presentations in this session

Presentation thumbnail
Associate Professor D. D'Amario (Novara, IT)
Abstract
Presentation thumbnail
Presentation thumbnail
Doctor L. Grigorian (Madrid, ES)
Abstract Slides
Presentation thumbnail
Mr P. Sadeghi Pour (Bristol, GB)
Abstract Slides
Presentation thumbnail
Doctor C. Edlinger (Salzburg, AT)
Abstract

Access the full session

Session thumbnail
Poster session 3 - Stem cells and cell therapy

The Event

Event poster

ESC Congress 2016

28 August 2016 14:00 CET
You may be interested in
thumbnail
Congress Presentation
Evaluation of intrapericardial regenerative therapy in a porcine myocardial infarction model: comparison between free versus microencapsulated CDCs delivery
29 June 2021
thumbnail
Congress Presentation
VasCraft: a human decellularized and re-endothelialized tissue-engineered vascular graft for coronary arterial revascularization
11 May 2026
thumbnail
Congress Presentation
Safety and efficacy of induced pluripotent stem cell-derived engineered human myocardium as biological ventricular assist tissue in term. heart failure (BioVAT-HF):trial design and experience at UKSH
21 May 2023
thumbnail
Congress Presentation
New advanced heart failure (HF) pig model with reduced ejection fraction and clinically relevant cardiopulmonary congestion.
29 June 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources